Longfeng Jiang

1.1k total citations
42 papers, 790 citations indexed

About

Longfeng Jiang is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Longfeng Jiang has authored 42 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 15 papers in Molecular Biology and 14 papers in Hepatology. Recurrent topics in Longfeng Jiang's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (6 papers). Longfeng Jiang is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (6 papers). Longfeng Jiang collaborates with scholars based in China, United States and United Kingdom. Longfeng Jiang's co-authors include Bibo Ke, Changyong Li, Tao Yang, Douglas G. Farmer, Ronald W. Busuttil, Jerzy W. Kupiec‐Weglinski, Qiang Zhu, Jun Li, Xiao Wang and Dongwei Xu and has published in prestigious journals such as Hepatology, JNCI Journal of the National Cancer Institute and International Journal of Molecular Sciences.

In The Last Decade

Longfeng Jiang

39 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longfeng Jiang China 16 300 235 199 169 98 42 790
Annamaria D’Aprile Italy 14 466 1.6× 227 1.0× 163 0.8× 151 0.9× 56 0.6× 21 958
Ali T. Abdallah Germany 12 267 0.9× 484 2.1× 269 1.4× 255 1.5× 119 1.2× 26 975
Gabriella B. Gajdos United States 15 440 1.5× 182 0.8× 101 0.5× 216 1.3× 256 2.6× 20 975
Chien‐Hao Huang Taiwan 16 240 0.8× 280 1.2× 123 0.6× 326 1.9× 116 1.2× 68 836
Vaggelis Harokopos Greece 14 466 1.6× 121 0.5× 129 0.6× 45 0.3× 73 0.7× 18 991
Marı́a-Luisa Gaspar Spain 21 395 1.3× 95 0.4× 471 2.4× 57 0.3× 119 1.2× 53 1.2k
Chloé Abels Belgium 6 262 0.9× 229 1.0× 569 2.9× 139 0.8× 89 0.9× 6 910
Xiangyong Li China 16 290 1.0× 196 0.8× 67 0.3× 163 1.0× 93 0.9× 53 838
Min Hu China 19 454 1.5× 333 1.4× 56 0.3× 59 0.3× 103 1.1× 38 1.2k
Zengdun Shi United States 12 330 1.1× 294 1.3× 100 0.5× 316 1.9× 118 1.2× 19 963

Countries citing papers authored by Longfeng Jiang

Since Specialization
Citations

This map shows the geographic impact of Longfeng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longfeng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longfeng Jiang more than expected).

Fields of papers citing papers by Longfeng Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longfeng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longfeng Jiang. The network helps show where Longfeng Jiang may publish in the future.

Co-authorship network of co-authors of Longfeng Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Longfeng Jiang. A scholar is included among the top collaborators of Longfeng Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longfeng Jiang. Longfeng Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Tao, et al.. (2025). Notch1 Inhibition Exacerbates APAP-Induced Liver Injury via β-Catenin and Macrophage Polarization. Frontiers in Bioscience-Landmark. 30(9). 43853–43853.
2.
Yu, Chengxiao, et al.. (2025). Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis. European journal of medical research. 30(1). 1014–1014.
3.
Zhang, Wen, Jiahui Wang, Yu‐Yun Shao, et al.. (2024). Hepatic SIRT6 protects against cholestatic liver disease primarily <i>via</i> inhibiting bile acid synthesis. Journal of Biomedical Research. 39(4). 340–340.
4.
Xu, Dongwei, X. B. Qu, Tao Yang, et al.. (2024). The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression. Experimental & Molecular Medicine. 56(8). 1843–1855. 13 indexed citations
5.
Yu, Mengyao, Shi-Chang Zhang, Longfeng Jiang, et al.. (2023). Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression. Frontiers in Cellular and Infection Microbiology. 13. 1082390–1082390. 3 indexed citations
6.
7.
Yang, Tao, Xiao Wang, Dongwei Xu, et al.. (2023). The macrophage STING-YAP axis controls hepatic steatosis by promoting the autophagic degradation of lipid droplets. Hepatology. 80(5). 1169–1183. 29 indexed citations
8.
Yang, Tao, Jiaying Zhao, Xiao Wang, et al.. (2023). Macrophage PTEN controls STING-induced inflammation and necroptosis through NICD/NRF2 signaling in APAP-induced liver injury. Cell Communication and Signaling. 21(1). 160–160. 28 indexed citations
9.
Qu, X. B., Tao Yang, Xiao Wang, et al.. (2023). Macrophage RIPK3 triggers inflammation and cell death via the XBP1–Foxo1 axis in liver ischaemia–reperfusion injury. JHEP Reports. 5(11). 100879–100879. 16 indexed citations
10.
Ding, Yuqing, Longfeng Jiang, Wei Zhao, et al.. (2022). The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound. Clinics and Research in Hepatology and Gastroenterology. 46(8). 101951–101951. 3 indexed citations
11.
Jiang, Longfeng, et al.. (2020). <p>WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling</p>. OncoTargets and Therapy. Volume 13. 7033–7044. 13 indexed citations
12.
Li, Sensen, Longfeng Jiang, Yanbing Yang, et al.. (2020). Siglec1 enhances inflammation through miR-1260-dependent degradation of IκBα in COPD. Experimental and Molecular Pathology. 113. 104398–104398. 8 indexed citations
13.
Dang, Yini, Longfeng Jiang, Jianfu Zhang, et al.. (2019). Disseminated histoplasmosis in an immunocompetent individual diagnosed with gastrointestinal endoscopy: a case report. BMC Infectious Diseases. 19(1). 992–992. 8 indexed citations
14.
Zhang, Yongting, Yuwen Li, Wenting Li, et al.. (2018). Therapeutic Effect of Human Umbilical Cord Mesenchymal Stem Cells at Various Passages on Acute Liver Failure in Rats. Stem Cells International. 2018. 1–11. 38 indexed citations
15.
Zhu, Qiang, Han Wang, Bin Jiang, et al.. (2018). Loss of ATF3 exacerbates liver damage through the activation of mTOR/p70S6K/ HIF-1α signaling pathway in liver inflammatory injury. Cell Death and Disease. 9(9). 910–910. 49 indexed citations
16.
Chen, Hua‐Jun, Hai‐Bin Shi, Longfeng Jiang, Lan Li, & Rong Chen. (2017). Disrupted topological organization of brain structural network associated with prior overt hepatic encephalopathy in cirrhotic patients. European Radiology. 28(1). 85–95. 9 indexed citations
17.
Chen, Hua‐Jun, et al.. (2016). Identifying minimal hepatic encephalopathy in cirrhotic patients by measuring spontaneous brain activity. Metabolic Brain Disease. 31(4). 761–769. 16 indexed citations
18.
Jiang, Longfeng, Lin Gan, Shanshan Li, et al.. (2013). [Sequence analysis of varicella-zoster virus gE gene in varicella-zoster virus strains with different clades].. PubMed. 29(2). 112–8. 1 indexed citations
19.
Jin, Ke, Yuan Liu, Nian Chen, et al.. (2013). A case of brucellosis displaying Parkinsonian-like tremor. The Journal of Infection in Developing Countries. 7(12). 1008–1011. 4 indexed citations
20.
Han, Yaping, Jun Li, Longfeng Jiang, et al.. (2013). Regulation of B7-H1 expression on peripheral monocytes and IFN-γ secretion in T lymphocytes by HBeAg. Cellular Immunology. 283(1-2). 25–30. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annamaria D’Aprile Breakdown of academic impact, for papers by Ali T. Abdallah Breakdown of academic impact, for papers by Gabriella B. Gajdos Breakdown of academic impact, for papers by Chien‐Hao Huang Breakdown of academic impact, for papers by Vaggelis Harokopos Breakdown of academic impact, for papers by Marı́a-Luisa Gaspar Breakdown of academic impact, for papers by Chloé Abels Breakdown of academic impact, for papers by Xiangyong Li Breakdown of academic impact, for papers by Min Hu Breakdown of academic impact, for papers by Zengdun Shi
Rankless by CCL
2026